Wear of Articular Bearing Surface of Prosthetic JointNCT06426641
Polyethylene Wear Particle Analysis of TKA
An observational study of Wear of Articular Bearing Surface of Prosthetic Joint and Total Knee Arthroplasty, run by Osaka Metropolitan University at 2 sites in 2 countries.
Trial summary
The purpose of this study was to investigate whether polyethylene (Vitamin E-containing polyethylene), which has been newly introduced and widely used clinically as a biomaterial for tibial inserts in total knee arthroplasty, but whose mid- to long-term clinical results are still unknown, is more effective than… Read more about this study
- Who is it for?
- Ages 20 years and older
- Conditions the study is for
- Wear of Articular Bearing Surface of Prosthetic Joint, Total Knee Arthroplasty
- What is being tested?
- Polyethylene
- Type of treatment
- Medical device
- How many people
- 90 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 5 Dec 2023to 31 Dec 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients undergoing revision surgery
Who may be able to join
- Patients undergoing revision knee arthroplasty within the study period
- Patients over 20 years old
- Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
- Patients who have passed 2 years or more since their first total knee arthroplasty
Who cannot join
- 1. Patients who are judged to be unsuitable as research subjects by the research physician
Trial locations and contacts
2 sites in 2 countries.
2 sites in 2 countries
About this study
Official title: Polyethylene Wear Particle Analysis of Total Knee Arthroplasty -International Multicenter Study-
The purpose of this study was to investigate whether polyethylene (Vitamin E-containing polyethylene), which has been newly introduced and widely used clinically as a biomaterial for tibial inserts in total knee arthroplasty, but whose mid- to long-term clinical results are still unknown, is more effective than conventional polyethylene.
Our goal is to clarify through an international multi-center joint study using in vivo polyethylene wear particle analysis, which the investigators developed as a method to provide early feedback, as to whether polyethylene wear debris production in vivo can be reduced.
Read the detailed description
Anticipated medical contribution and significance In this study, the investigators investigate whether a newly introduced polyethylene (highly cross-linked polyethylene, vitamin E-containing polyethylene in vivo) can suppress wear debris production more than conventional polyethylene. If the newly introduced polyethylene can reduce wear debris production, it is expected to reduce failure of artificial joints in the future. However, if newly introduced polyethylene is actually increasing wear debris production, it could be an early alarm bell for surgeons around the world. In other words, the international and social impact of this research is extremely large.
Two unique requirements are necessary to carry out this research. Firstly, in vivo analysis of polyethylene wear particles is possible, and secondly, the number of surgical cases of revision knee arthroplasty targeted for investigation is large. The first requirement is that the applicants have published many English-language papers on in vivo polyethylene wear debris analysis, and that their facilities are the most suitable and fully capable of carrying out the analysis worldwide. be. The second requirement is that the investigators need to collaborate not only with our hospital but also with facilities that perform a large number of revision knee arthroplasty surgeries. Not only our hospital, but also our affiliated hospital, which is one of the facilities in Japan that performs the most knee joint surgeries (Naniwa Ikuno Hospital), and the hospital that performs the most knee joint surgeries worldwide (Mayo Clinic [USA]). , Hospital for Special Surgery [USA], Istituto Ortopedico Rizzoli [Italy]).
Research method In this study, the investigators conducted the following steps to determine the in vivo wear particles (number, size, and morphology) of conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose mid- to long-term results have not yet been clarified. Clarifying the difference [Figure 3].
Target of this research In this study, the investigators will focus on patients undergoing revision knee arthroplasty as a routine medical treatment.
First total joint replacement
- 30 patients using polyethylene containing Vitamin E
- 30 patients using conventional polyethylene (no highly cross-linking)
- 30 patients using conventional polyethylene (with highly cross-linking)
Accumulation of periarticular tissue In this study, the investigators will focus on patients undergoing revision knee arthroplasty as a routine medical treatment.
The test will be conducted after obtaining approval from the ethics committee at each facility and obtaining informed consent. The pericapsular tissue, which is removed during surgery and usually discarded, is obtained and fixed in formalin fixative. The tissue will be transported to the Department of Orthopedic Surgery, Osaka Public University Graduate School of Medicine for analysis. International transportation of tissues requires outsourcing to specialized companies with experience in transporting tissues from overseas.
Isolation of polyethylene wear debris The collected tissue around the joint capsule is immersed in 5M NaOH at 65°C for 1 hour to decompose the protein. Make a sucrose layer (5, 10, 20%) in a 14ml tube (14PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the dissolved solution, and place in an ultracentrifuge (CP100a, P28S1014 rotor, Hitachi Koki). Ultracentrifuge at 28,000 rpm [103,7009g] for 3 hours at 4°C. Prepare an isopropanol layer (0.90 and 0.96 g/mL) in a 40 ml tube (40PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the upper layer of sucrose layer, and centrifuge at 28,000 rpm (103,7009 g ) and perform ultracentrifugation at 4°C for 1 hour. The isopropanol interlayer is collected to isolate polyethylene wear debris.
Analysis of polyethylene wear debris The isopropanol interlayer is filtered through a 0.1 μm polycarbonate filter (VCTP 013-00, Millipore Corporation, Bedford, MA). Dry the polycarbonate filter, fix it on an aluminum pedestal (M4, Nisshin EM Co, Ltd, Tokyo, Japan), and apply platinum coating (E-1030 ion sputter, Hitachi Science Systems Ltd, Tokyo, Japan). Observe the polyethylene wear particles on the polycarbonate filter using a scanning electron microscope (S4700SI, Hitachi Ltd, Tokyo, Japan), and analyze the following items using an image analyzer (Mac Scope, Mitani Co, Tokyo, Japan).
- Number of polyethylene wear particles (number per 1g of tissue)
- Size (Equivalent circle diameter [μm])
- Shape (aspect ratio, roundness)
Comparison of iv vivo polyethylene wear powder morphology depending on polyethylene material The number, size, and form of polyethylene wear debris will be compared between conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose medium- to long-term results have not yet been clarified.
The investigators also investigated factors that affect polyethylene wear in vivo (age, height, weight, period from initial surgery to revision surgery, knee joint range of motion, knee prosthesis clinical score [Knee Society Score, University of California at Los Angeles activity score]).
Evaluation items (outcome) Main evaluation items: Polyethylene wear particle morphology (number of wear particles, equivalent circle diameter [㎛], aspect ratio, roundness) [Reason for setting primary endpoints] Because it is a standard evaluation item for evaluating polyethylene wear debris.
Secondary endpoints:
- Body mass index
- Knee joint range of motion
- Clinical score (2011Knee Society Score, Knee injury and Osteoarthritis Outcome Score for Joint Replacement, University of California at Los Angeles activity score) [Reason for setting secondary endpoints] Because it may affect the production of polyethylene wear debris.
Planned number of research subjects and basis for setting it (including cases where the number of research subjects is set without relying on statistical grounds) Total 90 cases
- 30 patients using polyethylene containing Vitamin E
- 30 patients using conventional polyethylene (no high cross-linking)
- 30 patients using conventional polyethylene (with high cross-linking) Rationale for setting: The target number of cases was determined from the number of cases at related institutions within the study period.
- Being tested
- Polyethylene
- Keywords
- Polyethylene wear particle
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PolyethyleneDevice
There is no intervention
| Study group | Role | What they receive |
|---|---|---|
| polyethylene containing Vitamin E | polyethylene containing Vitamin E Receives: Device: Polyethylene | |
| conventional polyethylene (no highly cross-linking) | conventional polyethylene (no highly cross-linking) Receives: Device: Polyethylene | |
| conventional polyethylene (with highly cross-linking) | conventional polyethylene (with highly cross-linking) Receives: Device: Polyethylene |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of polyethylene wear particles
counts / g (tissue sample)
Measured: Time of revision surgery
Equivalent circle diameter of polyethylene wear particles
Equivalent circle diameter (㎛)
Measured: Time of revision surgery
Aspect ratio of polyethylene wear particles
Aspect ratio
Measured: Time of revision surgery
Roundness of polyethylene wear particles
Roundness
Measured: Time of revision surgery
Secondary outcomes (9)
Body mass index
kg/m2
Measured: Time of revision surgery
Knee joint extension angle
degrees
Measured: Time of revision surgery
Knee joint flexion angle
degrees
Measured: Time of revision surgery
2011 Knee Society Score: An "Objective" Knee Score
0(worse)-100(best)
Measured: Time of revision surgery
2011 Knee Society Score: A Patient Satisfaction Score
0(worse)-40(best)
Measured: Time of revision surgery
2011 Knee Society Score: A Patient Expectation Score
0(worse)-15(best)
Measured: Time of revision surgery
2011 Knee Society Score: A Functional Activity Score
0(worse)-100(best)
Measured: Time of revision surgery
Knee injury and Osteoarthritis Outcome Score for Joint Replacement
0(worse)-100(best)
Measured: Time of revision surgery
University of California at Los Angeles activity score
1(worse)-10(best)
Measured: Time of revision surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 May 2024
- Study start5 Dec 2023
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Wear of Articular Bearing Surface of Prosthetic JointStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Osaka Metropolitan University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yukihide Minoda, Osaka Metropolitan University
- Investigators
- Yukihide Minoda, MD, PhD, Principal investigator, Osaka Metropolitan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06426641
- Sponsor's protocol ID
- OMU 2023-108
- Status last verified
- Jan 2025
- First submitted
- 16 May 2024
- Last updated
- 17 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Publications
Minoda Y, Kobayashi A, Iwaki H, Iwakiri K, Inori F, Sugama R, Ikebuchi M, Kadoya Y, Takaoka K. In vivo analysis of polyethylene wear particles after total knee arthroplasty: the influence of improved materials and designs. J Bone Joint Surg Am. 2009 Nov;91 Suppl 6:67-73. doi: 10.2106/JBJS.I.00447. No abstract available.
PubMed 19884413Minoda Y, Kobayashi A, Iwaki H, Miyaguchi M, Kadoya Y, Ohashi H, Yamano Y, Takaoka K. Polyethylene wear particles in synovial fluid after total knee arthroplasty. Clin Orthop Relat Res. 2003 May;(410):165-72. doi: 10.1097/01.blo.0000063122.39522.c2.
PubMed 12771827
Study at a glance
From the registry record, last updated by the sponsor on 17 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Polyethylene Wear Particle Analysis of Total Knee Arthroplasty -International Multicenter Study-
- ClinicalTrials.gov ID
- NCT06426641
- Acronym / sponsor ID
- OMU 2023-108
- Keywords
- Polyethylene wear particle
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- Osaka Metropolitan UniversityUniversity, hospital or other
- Collaborators
- Mayo Clinic, Istituto Ortopedico Rizzoli, Hospital for Special Surgery, New York
- Study start
- 5 Dec 2023 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Dec 2028 (estimated)
- First posted
- 23 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study was to investigate whether polyethylene (Vitamin E-containing polyethylene), which has been newly introduced and widely used clinically as a biomaterial for tibial inserts in total knee arthroplasty, but whose mid- to long-term clinical results are still unknown, is more effective than conventional polyethylene.
Our goal is to clarify through an international multi-center joint study using in vivo polyethylene wear particle analysis, which the investigators developed as a method to provide early feedback, as to whether polyethylene wear debris production in vivo can be reduced.
Detailed description
Anticipated medical contribution and significance In this study, the investigators investigate whether a newly introduced polyethylene (highly cross-linked polyethylene, vitamin E-containing polyethylene in vivo) can suppress wear debris production more than conventional polyethylene. If the newly introduced polyethylene can reduce wear debris production, it is expected to reduce failure of artificial joints in the future. However, if newly introduced polyethylene is actually increasing wear debris production, it could be an early alarm bell for surgeons around the world. In other words, the international and social impact of this research is extremely large.
Two unique requirements are necessary to carry out this research. Firstly, in vivo analysis of polyethylene wear particles is possible, and secondly, the number of surgical cases of revision knee arthroplasty targeted for investigation is large. The first requirement is that the applicants have published many English-language papers on in vivo polyethylene wear debris analysis, and that their facilities are the most suitable and fully capable of carrying out the analysis worldwide. be. The second requirement is that the investigators need to collaborate not only with our hospital but also with facilities that perform a large number of revision knee arthroplasty surgeries. Not only our hospital, but also our affiliated hospital, which is one of the facilities in Japan that performs the most knee joint surgeries (Naniwa Ikuno Hospital), and the hospital that performs the most knee joint surgeries worldwide (Mayo Clinic [USA]). , Hospital for Special Surgery [USA], Istituto Ortopedico Rizzoli [Italy]).
Research method In this study, the investigators conducted the following steps to determine the in vivo wear particles (number, size, and morphology) of conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose mid- to long-term results have not yet been clarified. Clarifying the difference [Figure 3].
Target of this research In this study, the investigators will focus on patients undergoing revision knee arthroplasty as a routine medical treatment.
First total joint replacement
- 30 patients using polyethylene containing Vitamin E
- 30 patients using conventional polyethylene (no highly cross-linking)
- 30 patients using conventional polyethylene (with highly cross-linking)
Accumulation of periarticular tissue In this study, the investigators will focus on patients undergoing revision knee arthroplasty as a routine medical treatment.
The test will be conducted after obtaining approval from the ethics committee at each facility and obtaining informed consent. The pericapsular tissue, which is removed during surgery and usually discarded, is obtained and fixed in formalin fixative. The tissue will be transported to the Department of Orthopedic Surgery, Osaka Public University Graduate School of Medicine for analysis. International transportation of tissues requires outsourcing to specialized companies with experience in transporting tissues from overseas.
Isolation of polyethylene wear debris The collected tissue around the joint capsule is immersed in 5M NaOH at 65°C for 1 hour to decompose the protein. Make a sucrose layer (5, 10, 20%) in a 14ml tube (14PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the dissolved solution, and place in an ultracentrifuge (CP100a, P28S1014 rotor, Hitachi Koki). Ultracentrifuge at 28,000 rpm [103,7009g] for 3 hours at 4°C. Prepare an isopropanol layer (0.90 and 0.96 g/mL) in a 40 ml tube (40PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the upper layer of sucrose layer, and centrifuge at 28,000 rpm (103,7009 g ) and perform ultracentrifugation at 4°C for 1 hour. The isopropanol interlayer is collected to isolate polyethylene wear debris.
Analysis of polyethylene wear debris The isopropanol interlayer is filtered through a 0.1 μm polycarbonate filter (VCTP 013-00, Millipore Corporation, Bedford, MA). Dry the polycarbonate filter, fix it on an aluminum pedestal (M4, Nisshin EM Co, Ltd, Tokyo, Japan), and apply platinum coating (E-1030 ion sputter, Hitachi Science Systems Ltd, Tokyo, Japan). Observe the polyethylene wear particles on the polycarbonate filter using a scanning electron microscope (S4700SI, Hitachi Ltd, Tokyo, Japan), and analyze the following items using an image analyzer (Mac Scope, Mitani Co, Tokyo, Japan).
- Number of polyethylene wear particles (number per 1g of tissue)
- Size (Equivalent circle diameter [μm])
- Shape (aspect ratio, roundness)
Comparison of iv vivo polyethylene wear powder morphology depending on polyethylene material The number, size, and form of polyethylene wear debris will be compared between conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose medium- to long-term results have not yet been clarified.
The investigators also investigated factors that affect polyethylene wear in vivo (age, height, weight, period from initial surgery to revision surgery, knee joint range of motion, knee prosthesis clinical score [Knee Society Score, University of California at Los Angeles activity score]).
Evaluation items (outcome) Main evaluation items: Polyethylene wear particle morphology (number of wear particles, equivalent circle diameter [㎛], aspect ratio, roundness) [Reason for setting primary endpoints] Because it is a standard evaluation item for evaluating polyethylene wear debris.
Secondary endpoints:
- Body mass index
- Knee joint range of motion
- Clinical score (2011Knee Society Score, Knee injury and Osteoarthritis Outcome Score for Joint Replacement, University of California at Los Angeles activity score) [Reason for setting secondary endpoints] Because it may affect the production of polyethylene wear debris.
Planned number of research subjects and basis for setting it (including cases where the number of research subjects is set without relying on statistical grounds) Total 90 cases
- 30 patients using polyethylene containing Vitamin E
- 30 patients using conventional polyethylene (no high cross-linking)
- 30 patients using conventional polyethylene (with high cross-linking) Rationale for setting: The target number of cases was determined from the number of cases at related institutions within the study period.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| polyethylene containing Vitamin E | – | Device: Polyethylenepolyethylene containing Vitamin E |
| conventional polyethylene (no highly cross-linking) | – | Device: Polyethyleneconventional polyethylene (no highly cross-linking) |
| conventional polyethylene (with highly cross-linking) | – | Device: Polyethyleneconventional polyethylene (with highly cross-linking) |
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients undergoing revision surgery
Key inclusion criteria (4 listed)
- Patients undergoing revision knee arthroplasty within the study period
- Patients over 20 years old
- Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
- Patients who have passed 2 years or more since their first total knee arthroplasty
Key exclusion criteria (1 listed)
- 1. Patients who are judged to be unsuitable as research subjects by the research physician
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PolyethyleneThere is no intervention | Device | conventional polyethylene (no highly cross-linking), conventional polyethylene (with highly cross-linking), polyethylene containing Vitamin E |
Primary outcome
Number of polyethylene wear particles
Time frame: Time of revision surgery
counts / g (tissue sample)
Equivalent circle diameter of polyethylene wear particles
Time frame: Time of revision surgery
Equivalent circle diameter (㎛)
Aspect ratio of polyethylene wear particles
Time frame: Time of revision surgery
Aspect ratio
Roundness of polyethylene wear particles
Time frame: Time of revision surgery
Roundness
9 secondary outcomes
Body mass index
Time frame: Time of revision surgery
Knee joint extension angle
Time frame: Time of revision surgery
Knee joint flexion angle
Time frame: Time of revision surgery
2011 Knee Society Score: An "Objective" Knee Score
Time frame: Time of revision surgery
2011 Knee Society Score: A Patient Satisfaction Score
Time frame: Time of revision surgery
2011 Knee Society Score: A Patient Expectation Score
Time frame: Time of revision surgery
2011 Knee Society Score: A Functional Activity Score
Time frame: Time of revision surgery
Knee injury and Osteoarthritis Outcome Score for Joint Replacement
Time frame: Time of revision surgery
University of California at Los Angeles activity score
Time frame: Time of revision surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jan 2025.
- Results publication: PubMed 19884413Minoda Y, Kobayashi A, Iwaki H, Iwakiri K, Inori F, Sugama R, Ikebuchi M, Kadoya Y, Takaoka K. In vivo analysis of polyethylene wear particles after total knee arthroplasty: the influence of improved materials and designs. J Bone Joint Surg Am. 2009 Nov;91 Suppl 6:67-73. doi: 10.2106/JBJS.I.00447. No abstract available.
- Results publication: PubMed 12771827Minoda Y, Kobayashi A, Iwaki H, Miyaguchi M, Kadoya Y, Ohashi H, Yamano Y, Takaoka K. Polyethylene wear particles in synovial fluid after total knee arthroplasty. Clin Orthop Relat Res. 2003 May;(410):165-72. doi: 10.1097/01.blo.0000063122.39522.c2.
- Individual participant dataSharing planned: No
Related trials for Wear of Articular Bearing Surface of Prosthetic Joint
RecruitingObservational study
Polyethylene Wear Particle Analysis of THA
Wear of Articular Bearing Surface of Prosthetic Joint, Hip Arthropathy
Recruiting
Migration of CS vs CR Insert in TKA Using RSA
Wear of Articular Bearing Surface of Prosthetic Joint, Migration of Implant
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yukihide Minoda, MD, PhD principal investigator
Osaka Metropolitan University
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Wear of Articular Bearing Surface of Prosthetic Joint and Total Knee Arthroplasty, run by Osaka Metropolitan University at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 17 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States, Japan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of polyethylene wear particles (time frame: Time of revision surgery). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06426641, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2025.